BioAtla shares fall 10.29% after-hours as company initiates strategic review and announces 70% workforce reduction.

BioAtla Inc. fell 10.29% in after-hours trading following the announcement of a strategic review and significant restructuring measures. The company disclosed plans to explore asset sales, licensing deals, or partnerships to maximize shareholder value while implementing a 70% workforce reduction and expanding cost-containment efforts. These actions, aimed at addressing financial challenges, raised concerns about operational stability and execution risks, particularly as the company emphasized no assurance of successful transactions. The workforce cuts and restructuring, coupled with uncertainties surrounding the strategic review, likely triggered investor pessimism, reflecting doubts about BioAtla’s ability to sustain operations or generate value without external intervention. The lack of immediate updates or concrete outcomes from the strategic process further compounded market skepticism.